📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial. (2022)

First Author: Becker F

Attributed to: Using big data to improve population health and resource allocation for people with diabetes in Malaysia funded by Newton Fund

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.diabres.2021.109152

PubMed Identifier: 34813910

Publication URI: http://europepmc.org/abstract/MED/34813910

Type: Journal Article/Review

Volume: 183

Parent Publication: Diabetes research and clinical practice

ISSN: 0168-8227